Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-12 | New | $12,725,000 | $12,725,000 | Debt Only | 06b | SEC link |
| 2018-04-02 | New | $43,936,167 | $43,936,167 | Equity Only | 06b | SEC link |
| 2009-02-26 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Joseph F. Berry | Director |
| Ernest Bognar | Executive |
| Joe C. Cunningham | Director |
| Joe Cunningham, M.D. | Director |
| Mark Early | Executive |
| Harry R. Jacobson | Director |
| Harry Jacobson, M.D. | Director |
| Robert P. Landin | Director |
| Renee Larson | Executive |
| Thomas Lyles | Director |
| John Nemunaitis | Director, Executive |
| John Nemunaitis, M.D. | Director, Executive |
| Scott Seaman | Director |
| David M. Shanahan | Director, Executive |
| Gladice Wallraven | Executive |